The minimum efficiency of drugs against Alzheimer's disease
Deleuze, J.
La Revue du Praticien 61(9): 1187
2011
ISSN/ISBN: 0035-2640 PMID: 22308796 Document Number: 649428
Document emailed within 1 workday
Related Documents
Gillen, T.E.; Gregg, K.M.; Yuan, H.; Kurth, M.C.; Krishnan, K.R. 2001: Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease Psychopharmacology Bulletin 35(2): 83-96MacKenzie, I.R. 1996: Antiinflammatory drugs in the treatment of Alzheimer's disease Journal of Rheumatology 23(5): 806-808
Clader, J.W. 1999: Recent advances in cholinergic drugs for Alzheimer's disease Current Opinion in Drug Discovery and Development 2(4): 311-320
Peng, Y.; Li, P-ping.; Li, L.; Zhang, Y.; Hou, W-zhen.; Cui, D-dan.; Li, J.; Wang, L.; Wang, Q-li.; Wang, X-liang. 2016: Progress of clinical trials in Alzheimer's disease drugs Yao Xue Xue Bao 51(8): 1185-1195
Warner, J.; Butler, R. 2001: Drugs for Alzheimer's disease. more effective agents are needed Bmj 323(7321): 1127-1128
2003: Antibodies, antihypertensive drugs, antioxidants. Can they prevent Alzheimer disease? MMWFortschrittederMedizin 145(33-34): 60
Nordberg, A.; Eriksdotter-Jönhagen, M.; Garlind, A.; Grut, M.; Freund-Levi, Y.; Cornelius, C.; Ekström, A.; Fastbom, J.; Sedvall, M.; Viitanen, M. 2006: Administration of symptom-relieving drugs in Alzheimer disease is beneficial Lakartidningen 103(6): 369-371
De Jong, D.; Jansen, R.W.M.M.; Verbeek, M.M.; Kremer, H.P.H. 2002: The possible suppression of Alzheimer's disease by nonsteroidal anti-inflammatory drugs Nederlands Tijdschrift Voor Geneeskunde 146(44): 2074-2078
Hattori, H. 2013: Effectiveness and limitation of newly approved drugs for Alzheimer's disease Seishin Shinkeigaku Zasshi 115(1): 22-31
Otomo, E. 1988: Drug therapy of Alzheimer's disease. General concepts on nootropic drugs Nihon Rinsho. Japanese Journal of Clinical Medicine 46(7): 1569-1574
Mackell, J.A.; Ferris, S.H.; Mohs, R.; Schneider, L.; Galasko, D.; Whitehouse, P.; Schmitt, F.; Sano, M.; Thal, L.J. 1997: Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative Study Alzheimer Disease and Associated Disorders 11 Suppl. 2: S65-S69
Eleti, S. 2016: Drugs in Alzheimer's disease Dementia: An overview of current pharmacological management and future directions Psychiatria Danubina 28(Suppl-1): 136-140
Burov, I.V.; Baĭmanov, T.D.; Maĭsov, N.I. 1992: Effects of amiridin and tacrine, drugs effective in Alzheimer's disease, on synaptosomal uptake of neuromediators Biulleten' Eksperimental'noi Biologii i Meditsiny 113(4): 379-381
Fukatsu, R.; Tsuzuki, K.; Hayashi, Y.; Takamaru, Y.; Sasaki, N.; Yoshida, T.; Hatakeyama, Y.; Fuji, N.; Takahata, N. 1997: Recent advances in Alzheimer's disease research--amyloid precursor protein trafficking, processing, and mutations in Alzheimer's disease linked genes Hokkaido Journal of Medical Science 72(1): 3-11
Morris, J.C.; Edland, S.; Clark, C.; Galasko, D.; Koss, E.; Mohs, R.; van Belle, G.; Fillenbaum, G.; Heyman, A. 1993: The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease Neurology 43(12): 2457-2465
Morris, J.C.; Mohs, R.C.; Rogers, H.; Fillenbaum, G.; Heyman, A. 1988: Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease Psychopharmacology Bulletin 24(4): 641-652
Miyakawa, T. 1988: Brain pathology in Alzheimer's disease. Ultrastructure of amyloid fibrils in Alzheimer's disease and Down's syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 46(7): 1471-1474
Szpak, G.M.; Lechowicz, W.; Lewandowska, E.; Bertrand, E.; Wierzba-Bobrowicz, T.; Gwiazda, E.; Schmidt-Sidor, B.; Dymecki, J. 2001: Neurones and microglia in central nervous system immune response to degenerative processes. Part 1: Alzheimer's disease and Lewy body variant of Alzheimer's disease. Quantitative study Folia Neuropathologica 39(3): 181-192
Bufill, E.; Blesa, R. 2006: Alzheimer's disease and brain evolution: is Alzheimer's disease an example of antagonistic pleiotropy? Revista de Neurologia 42(1): 25-33
Fărcăşel, L. 1988: Current data on the anatomy and physiopathology of Alzheimer's disease (Alzheimer-type senile dementia--ATSD) Revista Medico-Chirurgicala A Societatii de Medici Si Naturalisti Din Iasi 92(2): 289-292